Comparing Ixekizumab vs Risankizumab
| Ixekizumab | Risankizumab |
|
|---|
| Ixekizumab | Risankizumab |
|
|---|---|---|
|
Prescription only
Prescribed for Ankylosing Spondylitis, Plaque Psoriasis, Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, Psoriasis. Ixekizumab may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis, Psoriasis, Plaque Psoriasis. Risankizumab may also be used for purposes not listed in this medication guide. |
Related suggestions |
| More about Ixekizumab | More about Risankizumab | |
| Ratings & Reviews | ||
|
Ixekizumab has an average rating of 7.2 out of 10 from a total of 233 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
Risankizumab has an average rating of 7.9 out of 10 from a total of 67 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 12% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Ixekizumab side effects |
View all Risankizumab side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Taltz | Skyrizi | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
312 hours |
672 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 191 drugs are known to interact with Ixekizumab:
|
A total of 191 drugs are known to interact with Risankizumab:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
| First Approval Date | ||
|
N/A |
April 23, 2019 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Dexamethasone
Dexamethasone is used to treat inflammatory conditions such as allergies, skin conditions ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.